Show simple item record

dc.contributor.authorTøndervik, Anne
dc.contributor.authorAarstad, Olav Andreas
dc.contributor.authorAune, Randi
dc.contributor.authorMaleki, Susan
dc.contributor.authorRye, Philip D
dc.contributor.authorDessen, Arne
dc.contributor.authorSkjåk-Bræk, Gudmund
dc.contributor.authorSletta, Håvard
dc.date.accessioned2022-10-12T12:21:45Z
dc.date.available2022-10-12T12:21:45Z
dc.date.created2021-01-19T11:46:35Z
dc.date.issued2020
dc.identifier.citationMarine Drugs. 2020, 18:565 (11), 1-14.en_US
dc.identifier.issn1660-3397
dc.identifier.urihttps://hdl.handle.net/11250/3025609
dc.language.isoengen_US
dc.publisherMDPIen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.subjectpotentiation of antibiotic effecten_US
dc.subjectguluronate oligomersen_US
dc.subjectmannuronan C-5 epimerasesen_US
dc.subjectseaweed and bacterial alginateen_US
dc.titleExploiting mannuronan C-5 epimerases in commercial alginate productionen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holder© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).en_US
dc.source.pagenumber1-14en_US
dc.source.volume18en_US
dc.source.journalMarine Drugsen_US
dc.source.issue11en_US
dc.identifier.doi10.3390/md18110565
dc.identifier.cristin1874181
dc.source.articlenumber565en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Navngivelse 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse 4.0 Internasjonal